Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis.

Sayed, Ahmed; Munir, Malak; Nabet, Mohamed Salah; Alghamdi, Badrah S; Ashraf, Ghulam Md; Bahbah, Eshak I; Elfil, Mohamed

Sayed, Ahmed; Munir, Malak; Nabet, Mohamed Salah; Alghamdi, Badrah S; Ashraf, Ghulam Md; Bahbah, Eshak I; Elfil, Mohamed.

Afiliação

Sayed A; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Munir M; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Nabet MS; Department of Pharmaceutics, School of Pharmacy, Zagazig University, Sharkia, Egypt.
Alghamdi BS; Department of Physiology, Neuroscience Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Ashraf GM; Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Bahbah EI; Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Elfil M; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.

Mediators Inflamm ; 2022: 2924773, 2022.

Article em En | MEDLINE | ID: mdl-35281427

Assuntos

Proteínas Sanguíneas; Galectina 3; Galectinas; Acidente Vascular Cerebral; Biomarcadores; Proteínas Sanguíneas/análise; Galectinas/análise; Humanos; Incidência; Prognóstico; Acidente Vascular Cerebral/epidemiologia; Acidente Vascular Cerebral/etiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Acidente Vascular Cerebral / Galectinas / Galectina 3 Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google